Ready-to-use stem cell therapies for pets coming soon? Gallant closes $18M Series B funding | Technology News
A US-based startup focused on curing pet health issues with ready-to-use stem cell therapies has secured over $18 million in fresh funding. Founded by Aaron Hirschhorn, Gallant is working to bring the first US FDA-approved, off-the-shelf stem cell therapy in veterinary medicine to market. Its latest funding round was led by existing backer Digitalis Venture … Read more